Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $276.97M.
ENTERPRISE VALUE (EV)
$276.97M
Kyverna Therapeutics, Inc.
Market Cap
$376.32M
Enterprise Value (EV)
$276.97M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Kyverna Therapeutics, Inc. (KYTX) | $376.32M | $276.97M |
| Arcturus Therapeutics Holdings Inc. (ARCT)vs › | $376.75M | $208.20M |
| Canopy Growth Corporation (CGC)vs › | $374.16M | $332.41M |
| YD Bio Limited Ordinary Shares (YDES)vs › | $381.78M | N/A |
| Orthofix Medical Inc. (OFIX)vs › | $385.22M | $516.03M |
| REGENXBIO Inc. (RGNX)vs › | $390.32M | $422.78M |
| Embecta Corp. (EMBC)vs › | $361.90M | $1.65B |
| Opus Genetics, Inc. (IRD)vs › | $361.23M | $307.35M |
| Turn Therapeutics Inc. (TTRX)vs › | $357.33M | $353.16M |
| Ocugen, Inc. (OCGN)vs › | $356.07M | $344.00M |
Market Cap
$376.32M
Total Debt
$24.74M
Cash
$124.09M
Enterprise Value
$276.97M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
